trending Market Intelligence /marketintelligence/en/news-insights/trending/Dm7SjvcuL2D6oOMFjs4xXA2 content esgSubNav
In This List

Maricann Group appoints CFO

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Maricann Group appoints CFO

Maricann Group Inc. appointed Scott Langille as CFO, effective Oct. 2, subject to regulatory approval.

Previously, the company's CEO Ben Ward had taken the additional role of interim CFO.

Langille was formerly CFO of Tribute Pharmaceuticals Canada Inc., which was sold to Pozen Inc. in February 2016 for $160 million to form Aralez Pharmaceuticals Inc.